Archive | Myth buster

Vascular dementia – where are the drugs?

Dr Laura PhippsKirsty MaraisClaire LucasRobin BrisbourneKaty StubbsFaye Monk

With each heartbeat, blood vessels deliver around 15% of your blood up into your brain. This energy-hungry organ can only keep going thanks to the constant supply of nutrients and oxygen that are carried to it in the blood. Hundreds of miles of arteries, veins and capillaries circulate blood around every inch of the brain. […]

Five things you may not know about frontotemporal dementia

Dr Laura PhippsKirsty MaraisClaire LucasRobin BrisbourneKaty StubbsFaye Monk

In awareness-raising messages about dementia, the spotlight typically rests on Alzheimer’s disease as the most common cause of dementia, helping people to learn more about the condition and working to break down the stigma that surrounds it. However, at Alzheimer’s Research UK, you’ll often see “the power to defeat dementia” next to our logo because […]

A Walk Through Dementia

Tim Parry

As one of the world’s leading dementia charities, we take serious our role of communicating the impact of dementia on society, on families and, of course, the individual. While our scientists have a battle on their hands finding new ways to fight the disease processes behind dementia, there’s another battle to win in moving the […]

Read more

The future of dementia is orange

Hilary Evans

Hopefully you’ve had the chance to take a look at our thought-provoking new campaign film #sharetheorange featuring ARUK supporter Christopher Eccleston. Why have we taken this unusual approach to communication? And what’s with the orange? There’s a simple answer to the first question: if there’s one health issue that would benefit from different way of […]

Read more

In the news: Could Alzheimer’s proteins be passed between people?

Dr Laura PhippsKirsty MaraisClaire LucasRobin BrisbourneKaty StubbsFaye Monk

In the news today, we’re hearing about a UK research study that has suggested the hallmark Alzheimer’s protein, amyloid, could have been passed between people in historic treatments with human-derived growth hormone in the 60s and 70s. This is one of the first suggestions that amyloid could pass between humans in a similar way to […]

Cracking dementia: the challenge of our generation

Dr Simon Ridley

In the 1980s the world sat up and took notice of AIDS spreading through groups across the world – quickly identified by scientists as caused by the human immunodeficiency virus (HIV). What happened in this decade in response to the growing epidemic was a collective movement across society. Activism driven by community groups, as well […]

Read more

International Clinical Trials Day: The power of clinical research to find a cure

Dr Laura PhippsKirsty MaraisClaire LucasRobin BrisbourneKaty StubbsFaye Monk

As International Clinical Trials Day conveniently falls in the middle of Dementia Awareness Week, it is the perfect opportunity to talk about how clinical trials are changing the future for dementia. Dementia doesn’t discriminate between age, ethnicity or wealth, and there are currently 850,000 people living with dementia in the UK. With no new treatments […]

In the news: B vitamins and Alzheimer’s disease

Dr Laura PhippsKirsty MaraisClaire LucasRobin BrisbourneKaty StubbsFaye Monk

A new analysis of several clinical trials has drawn a conclusion that will dismay many: taking B vitamins does not slow the decline in memory and thinking skills that comes with age. The results suggest that B vitamins are unlikely to prevent Alzheimer’s disease. The news is the opposite of what we, and the hundreds of thousands of […]